APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 64 filers reported holding APREA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 4 | -100.0% | 0.00% | – |
| Q1 2022 | $55,000 | -90.2% | 29,509 | -84.9% | 0.00% | – |
| Q4 2021 | $559,000 | -41.2% | 194,814 | +4.7% | 0.00% | – |
| Q3 2021 | $951,000 | +223.5% | 185,983 | +208.4% | 0.00% | – |
| Q2 2021 | $294,000 | +245.9% | 60,315 | +264.4% | 0.00% | – |
| Q1 2021 | $85,000 | +431.2% | 16,550 | +380.3% | 0.00% | – |
| Q4 2020 | $16,000 | -73.8% | 3,446 | +28.6% | 0.00% | – |
| Q3 2020 | $61,000 | -35.1% | 2,680 | +10.5% | 0.00% | – |
| Q2 2020 | $94,000 | -13.0% | 2,425 | -22.0% | 0.00% | – |
| Q1 2020 | $108,000 | +11.3% | 3,108 | +47.6% | 0.00% | – |
| Q4 2019 | $97,000 | – | 2,105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,259,662 | $6,437,000 | 2.66% |
| COASTAL INVESTMENT MANAGEMENT, L.P. | 41,965 | $214,000 | 0.30% |
| Redmile Group, LLC | 694,918 | $3,551,000 | 0.06% |
| Quantamental Technologies LLC | 13,752 | $70,000 | 0.05% |
| KENNEDY CAPITAL MANAGEMENT LLC | 342,486 | $1,750,000 | 0.04% |
| PDT Partners, LLC | 87,734 | $448,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 75,000 | $383,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 49,100 | $251,000 | 0.01% |
| NEXT Financial Group, Inc | 11,347 | $58,000 | 0.01% |
| Sugarloaf Wealth Management, LLC | 1,500 | $8,000 | 0.00% |